Apologies, I should have worded that question differently. That said, each of these 50 new formulations have a specific commercial purpose following R&D with numerous companies, atleast that was my understanding.
Either way, I think that the approval of this application would still warrant an announcement, or mention in the quarterly at best.
ADO ... Chart, page-43
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17857 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 20000 | 1 |
View Market Depth
| Last trade - 13.31pm 16/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable